Clinical Trial Update: The Use of Metformin in Early Breast Cancer Patients Pre-Surgery [EARLY_Phase 1]

View source ↗

Summary

A Phase 1 study investigating metformin in patients with early breast cancer prior to surgery has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• metformin (metformin)

Snippet

Sponsor: Instituto Nacional de Cancer, Brazil | Conditions: Breast Cancer | EARLY_Phase 1 | Status: WITHDRAWN